Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of Metformin for Diabetes and Cancer Treatment
Min Li, M Kellis, Huijie Zhang, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi, Olivia M. Farr, Stergios A. Pοlyzos, et al.
Metabolism (2018) Vol. 92, pp. 170-192
Open Access | Times Cited: 229
Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences
Éric Fontaine
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 212
Association of metformin use and cancer incidence: a systematic review and meta-analysis
Lauren E. O’Connor, Maeve Bailey‐Whyte, Manami Bhattacharya, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 4, pp. 518-529
Closed Access | Times Cited: 20
Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
Justine Bellier, Marie‐Julie Nokin, Eva Lardé, et al.
Diabetes Research and Clinical Practice (2019) Vol. 148, pp. 200-211
Closed Access | Times Cited: 116
Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Cheng-Ann Winston Ng, Amy Jiang, Emma Min Shuen Toh, et al.
International Journal of Colorectal Disease (2020) Vol. 35, Iss. 8, pp. 1501-1512
Closed Access | Times Cited: 91
Metformin: An old drug against old age and associated morbidities
Teresa Salvatore, Pia Clara Pafundi, Floriana Morgillo, et al.
Diabetes Research and Clinical Practice (2020) Vol. 160, pp. 108025-108025
Closed Access | Times Cited: 74
Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges
Wanru Zhang, Yaping An, Xiali Qin, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 73
Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
Weikun Jia, Tao Bai, Jiang Zeng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 59
Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms
А. О. Шпаков
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 42-42
Open Access | Times Cited: 56
Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Keywan Mortezaee, Dheyauldeen Shabeeb, Ahmed Eleojo Musa, et al.
Current Clinical Pharmacology (2019) Vol. 14, Iss. 1, pp. 41-53
Closed Access | Times Cited: 73
Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes
Lin Jiating, Ji Buyun, Yinchang Zhang
BioMed Research International (2019) Vol. 2019, pp. 1-6
Open Access | Times Cited: 71
Systems biology based drug repositioning for development of cancer therapy
Beste Turanlı, Özlem Altay, Jan Borén, et al.
Seminars in Cancer Biology (2019) Vol. 68, pp. 47-58
Closed Access | Times Cited: 70
Metformin and Breast Cancer: Molecular Targets
João Faria, G. Negalha, Ana Azevedo, et al.
Journal of Mammary Gland Biology and Neoplasia (2019) Vol. 24, Iss. 2, pp. 111-123
Closed Access | Times Cited: 68
The role of an anti-diabetic drug metformin in the treatment of endocrine tumors
Shilpa Thakur, Brianna Daley, Joanna Kłubo-Gwieździńska
Journal of Molecular Endocrinology (2019) Vol. 63, Iss. 2, pp. R17-R35
Open Access | Times Cited: 55
Mechanisms of metformin inhibiting cancer invasion and migration.
Yong Chang Chen, He Li, Jing Wang
PubMed (2020) Vol. 12, Iss. 9, pp. 4885-4901
Closed Access | Times Cited: 52
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases
Xinpeng Yin, Yuan Chen, Rexiati Ruze, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
Mirian Galliote Morale, Rodrigo Esaki Tamura, Ileana Gabriela Sanchez Rubio
Biomolecules (2022) Vol. 12, Iss. 3, pp. 357-357
Open Access | Times Cited: 31
Metformin enhances anti-cancer properties of resveratrol in MCF-7 breast cancer cells via induction of apoptosis, autophagy and alteration in cell cycle distribution
Reihaneh Fatehi, Marzieh Rashedinia, Amin Reza Akbarizadeh, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 644, pp. 130-139
Closed Access | Times Cited: 30
Fluorescence Imaging of Diabetic Cataract-Associated Lipid Droplets in Living Cells and Patient-Derived Tissues
Shuai Guo, Chen Li, Lili Lian, et al.
ACS Sensors (2023) Vol. 8, Iss. 10, pp. 3882-3891
Closed Access | Times Cited: 19
Metabolic disorders in prediabetes: From mechanisms to therapeutic management
Wen-Xin Ping, Shan Hu, Jingqian Su, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 3, pp. 361-377
Open Access | Times Cited: 6
Metformin prevents the pathological browning of subcutaneous white adipose tissue
Christopher Auger, Carly M. Knuth, Abdikarim Abdullahi, et al.
Molecular Metabolism (2019) Vol. 29, pp. 12-23
Open Access | Times Cited: 49
Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
Akira Saito, Joji Kitayama, Hisanaga Horie, et al.
Cancer Science (2020) Vol. 111, Iss. 11, pp. 4012-4020
Open Access | Times Cited: 43
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
Güven Yenmiş, Elif Yaprak Saraç, Nail Beşli, et al.
Acta Histochemica (2021) Vol. 123, Iss. 4, pp. 151709-151709
Closed Access | Times Cited: 34
Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
Gurjit Kaur Bhatti, Anshika Gupta, Paras Pahwa, et al.
Biomedical Journal (2022) Vol. 45, Iss. 5, pp. 733-748
Open Access | Times Cited: 27
Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review
Ruolin Li, Fereshteh Shokri, A. Rincón, et al.
Genes (2023) Vol. 14, Iss. 8, pp. 1572-1572
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top